Naviris, Eurosam Get $1.65 Billion Contract to Upgrade French, Italian Frigates
By Mauro Orru
European joint ventures Naviris and Eurosam have secured a contract worth 1.5 billion euros ($1.65 billion) to upgrade French and Italian warships.
The two joint ventures said Monday that they had won the contract from the Organisation for Joint Armament Cooperation, a European intergovernmental body, to modernize the frigates with a new generation of principal anti-air missile system and long-range radar.
Naviris is an equally split joint venture of Fincantieri and Naval Group. Eurosam is a joint venture of Thales and MBDA, in turn a joint venture of Airbus, BAE Systems and Leonardo.
France and Italy's Horizon warships were originally built between 2000 and 2010.
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94
(END) Dow Jones Newswires
July 31, 2023 09:58 ET (13:58 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Paramount Earnings: CEO Has Gone, For-Sale Sign Is Up; Good Results Would’ve Been Nice to Learn
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure